We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Should Consider Reclassifying TB Devices, Panel Recommends
FDA Should Consider Reclassifying TB Devices, Panel Recommends
July 8, 2011
The FDA’s Microbiology Devices advisory panel has unanimously recommended that the FDA consider down-classifying certain diagnostic tests for tuberculosis (TB) infections.